Medical expertise firm AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a web loss for the primary quarter of 2026. Revenues elevated 12.2% on a year-over-year foundation.
- Internet gross sales for the primary quarter elevated 12.2% year-over-year to $75.7 million; Med Tech gross sales grew 26% to $35.3 million
- At $40.4 million, Med System gross sales have been up 2.3% in Q1, in comparison with $39.5 million within the prior-year interval
- The corporate recorded a web lack of $10.9 million or $0.26 per share for Q1, vs. a lack of $12.8 million or $0.31 per share final yr
- Excluding particular gadgets, adjusted web loss was $4.2 million or $0.10 per share, in comparison with $4.4 million or $0.11 per share in Q1 2025
- Adjusted EBITDA, excluding one-off gadgets, was $2.2 million, in comparison with a lack of $0.2 million within the first quarter of 2025
- The administration stated it continues to anticipate to be money circulate optimistic for the complete fiscal yr 2026
- The corporate raised its FY26 web gross sales steering to $308-313 million from the sooner outlook of $305-310 million
- It now expects a loss per share within the vary of $0.33 to $0.23 for FY26, in comparison with the earlier forecast for a loss per share between $0.35 and $0.25
